Medicine and Dentistry
Robot-Assisted Prostatectomy
100%
Partial Nephrectomy
83%
Cystectomy
83%
Continence
43%
Recurrent Disease
38%
Neoplasm
36%
Prostate Cancer
35%
Retrospective Study
33%
Heart Death
33%
Kidney Transplantation
33%
Neoadjuvant Chemotherapy
33%
Retroperitoneal Lymph Node Dissection
33%
Urinary System
33%
Neutrophil Gelatinase Associated Lipocalin
33%
Bleeding
31%
Overall Survival
31%
Cancer Specific Survival
26%
Delayed Graft Function
25%
Urine Incontinence
23%
Bladder Cancer
22%
Recurrence Free Survival
19%
Urinary Diversion
18%
Postoperative Ileus
18%
Kidney Tumour
18%
Glomerular Filtration Rate
17%
Legionella
16%
Pyelonephritis
16%
Tissue Inhibitor of Metalloproteinase 1
16%
Long Term Survival
16%
Ileal Conduit
16%
Brachytherapy
16%
Inferior Vena Cava
16%
Magnetic Resonance Imaging
16%
Transitional Cell Carcinoma
16%
Muscle Invasive Bladder Cancer
16%
Thrombectomy
16%
Computer Assisted Tomography
16%
Radical Nephrectomy
16%
Postoperative Period
16%
Da Vinci Surgical System
16%
Propensity Score Matching
16%
Operation Duration
15%
Ischemia
13%
Ileus
12%
Multivariate Analysis
10%
Geriatrics
10%
Urethrectomy
9%
Symptom
8%
Lenabasum
8%
Antimicrobial Therapy
8%
Keyphrases
Robot-assisted Radical Prostatectomy
33%
Secondary Bladder Cancer
16%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
16%
Deep Ensemble
16%
Robot-assisted Radical Nephrectomy
16%
High-grade Prostate Cancer
16%
Ensemble Machine Learning
16%
Nerve Sparing
16%
Inferior Vena Cava Thrombectomy
16%
Kidney Transplantation
16%
Pentafecta Outcomes
16%
Delayed Graft Function
16%
Donation after Cardiac Death
16%
Intracorporeal Ileal Conduit
16%
Organ Recovery
16%
Resistance to Immunotherapy
16%
Intraoperative Navigation
16%
High Complexity
16%
Selective Clamping
16%
Laparoscopic Retroperitoneal Lymph Node Dissection
16%
Partial Nephrectomy
16%
Outcome Patterns
16%
Computed Tomography
16%
Upper Urinary Tract Infection
16%
Alanine-serine-cysteine Transporter
16%
Bladder Eversion
16%
Vesicoureteral Reflux
16%
Non-invasive Biomarkers
16%
Renal Scarring
16%
Legionella Pneumonia
16%
AR-V7
16%
Androgen Receptor Splice Variant
16%
Hugo RAS
13%
RAS System
13%
Urinary NGAL
12%
Bladder Neck Reconstruction
12%
Urethral Recurrence
12%
Postoperative Day
11%
Systemic Symptoms
11%
Postoperative Pneumonia
11%
Antimicrobial Therapy
11%
Geriatric 8
10%
Rectus Fascia
8%
Cystopexy
8%
22Rv1
8%
Burch Colposuspension
8%
Simple Machine
7%
Reflux
7%
Estimated Glomerular Filtration Rate
5%
Bacterial Pneumonia
5%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
33%
Malignant Neoplasm
21%
Immunotherapy
20%
Vesicoureteral Reflux
18%
Urinary Tract Infection
16%
Tissue Inhibitor of Metalloproteinase 1
16%
Recurrence Risk
16%
Androgen Receptor
16%
Tryptophan 2,3 Dioxygenase
16%
Pyelonephritis
16%
Heat Shock Protein 27
16%
Muscle Invasive Bladder Cancer
16%
Docetaxel
16%
Bladder Cancer
16%
Neutrophil Gelatinase Associated Lipocalin
16%
Racemase
16%
Delayed Graft Function
16%
Heart Death
16%
Biochemical Recurrence
16%
Neoplasm
16%
Renal Cell Carcinoma
16%
Chemotherapy
16%
Rat Model
16%
Indoleamine 2,3 Dioxygenase
11%
Kidney Metastasis
11%
Overall Survival
10%
Biological Marker
9%
Western Blot
7%
Scar Formation
7%
Kynurenine
7%
Immune Checkpoint Inhibitor
7%
Cancer Specific Survival
6%
Recurrence Free Survival
6%
